Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Novartis buys eczema drug in €95m deal

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …
News

PhRMA take on PBM’s in response to Trump drug price plan

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …
News
28246711066_52e38bc591_z

MPs vote to stay in EMA after Brexit

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …
News
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
News
david_horn_solomon

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
Appointment
patient_graphic

Recruitment and retention: How can we do better?

July 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …
Feature
gsk_boronia_australia

GSK confirms £250m deal to sell experimental drug to Dermavent Sciences

July 13, 2018 Medical Communications Dermavent, GSK, Roivant, tapinarof

British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …
News
johnson_and_johnson_jj

J&J ordered to pay $4.68 billion to talc-powder plaintiffs

July 13, 2018 Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …
News

Alvogen court case causes Nevada Judge to halt execution

July 13, 2018 Medical Communications Alvogen, Nevada, court, execution, lethal injection

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer …
News
takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro clears Phase 3 endpoint as maintenance therapy in multiple myeloma

July 12, 2018 Medical Communications, Research and Development Ninlaro, Takeda, multiple myeloma, pharma

After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Pfizer, Sanofi, Trump, top 10

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …
News
mario_saltarelli_cropped

Syntimmune appoints Pfizer, AbbVie veteran as new CMO

July 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, John Hopkins University, Pfizer, Syntimmune

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …
Appointment

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018 Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …
News

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Feature
sicorbio

Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs

July 6, 2018 Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026